Ali points out that the retatrutide clinical trials are lasting longer than previous trials for already approved GLP-1 drugs
Updated April 1, 2025
The net result is a measurable shift in appetites and diet patterns resulting in less processed food, and greater consumption of nutritionally dense, unprocessed items (Dilley et al., 2025)
The symptoms are caused by an exaggerated spillover of bile acids from the small intestine to the large intestine due to increased bile acid synthesis in the liver and/or decreased reabsorption of bile acids in the small intestine
Just a few weeks after a Super Bowl commercial for a company that sells compounded GLP-1 anti-obesity medications ignited controversy, the Food and Drug Administration (FDA) has determined that the shortage of semaglutide (Ozempic, Wegovy and Rybelsus) is over
Amylins physiological roles include inhibition of glucagon secretion, reduction in food intake, delay in gastric emptying, activation of brown adipose tissue via the sympathetic nervous system, and increased energy expenditure, ultimately leading to decreased blood glucose levels and weight loss [95]
